TRANSFORM MS CICActive
Key figures
Like most small UK companies, TRANSFORM MS CIC does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Balance sheet structure
Filed accounts2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 6,289 | 62,179 | 255,804 | 161,399 | 25,267 |
| Total assets | 8,113 | 120,419 | 264,729 | 297,852 | 219,348 |
| Total liabilities | 6,242 | 108,337 | 208,819 | 260,071 | 59,727 |
| Net assets / total equity | 1,871 | 12,082 | 55,910 | 37,781 | 48,553 |
| Average number of employees | 5 | 5 | 5 | 6 | 14 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company is the provision of services based on expertise in health measurement science and multiple sclerosis care.
As described in the company's latest filed accounts.
Summary: TRANSFORM MS CIC
Company
TRANSFORM MS CIC is a community interest company registered with Companies House under company number 12349146. It was incorporated on 4 Dec 2019. Its status is active. The registered office is in Plymouth (PL6). Its nature of business (SIC 2007) is research and experimental development on social sciences and humanities (72200).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £48,553, up 28.5% on the previous year. Cash at bank and in hand was £25,267. Total assets were £219,348 and total liabilities £59,727. The company had an average of 14 employees. Figures are available for 5 financial years (2021–2025).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 17 Dec 2026.